The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A population-level analysis of survival in patients with ALK+ anaplastic large cell lymphoma (ALCL) in the era of novel therapies.
 
Rahul Mishra
No Relationships to Disclose
 
Danai Dima
No Relationships to Disclose
 
Arda Durmaz
No Relationships to Disclose
 
Agrima Mian
No Relationships to Disclose
 
Sudipto Mukherjee
Honoraria - Aplastic Anemia and MDS International Foundation; McGraw-Hill Education
Consulting or Advisory Role - Abbvie/Genentech; Blueprint Medicines; Bristol Myers Squibb; EUSA Pharma; Novartis; OncLive; Paradigm
Speakers' Bureau - EUSA Pharma
Research Funding - BMS (formerly Celgene) (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
Paolo Fabrizio Caimi
Honoraria - Gilead Sciences
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb/Celgene; Genentech; Genmab; Incyte; Kite, a Gilead company; Lilly; MEI Pharma; Novartis; Takeda
Research Funding - Abbvie; ADC Therapeutics; Genentech; Luminary Therapeutics
Patents, Royalties, Other Intellectual Property - XaTEC patent holder (I)
(OPTIONAL) Uncompensated Relationships - Abcon Therapeutics; Luminary Therapeutics
 
Deepa Jagadeesh
Consulting or Advisory Role - AFM; Daiichi Sankyo/Lilly; Genmab
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Debiopharm Group (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); MEI Pharma (Inst); Merck (Inst); Regeneron (Inst); Rhizen Pharmaceuticals (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Trillium Therapeutics (Inst)